🇺🇸 FDA
Patent

US 12162837

Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same

granted A61KA61K31/445A61K31/4523

Quick answer

US patent 12162837 (Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same) held by Mebias Discovery, Inc. expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Mebias Discovery, Inc.
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/445, A61K31/4523, A61K45/06, A61P